AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3400679 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoperazone 2 g intravenously every 12 hours and mezlocillin 4 g intravenously every six hours
Number of subjects: 78
Study 3400679 — intervention group
Group type: COMPARATOR
Intervention: Imipenem/cilastatin 500 mg intravenously over 30 to 60 minutes every six hours
Number of subjects: 78
Study 3400679 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoperazone and mezlocillin
Number of subjects: 78
Study 3400679 — intervention group
Group type: COMPARATOR
Intervention: Imipenem/cilastatin
Number of subjects: 78
Study 29499675 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-delivered cognitive behavioural therapy (iCBT) for 8 weeks duration with regular post-session feedback by Psychological Wellbeing Practitioners
Number of subjects: 0
Study 29499675 — intervention group
Group type: COMPARATOR
Intervention: waitlist control group
Number of subjects: 0
Study 27508467 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent polyurethane film
Number of subjects: 25
Study 27508467 — intervention group
Group type: COMPARATOR
Intervention: Hydrocolloid dressing
Number of subjects: 25
Study 25697860 — intervention group
Group type: EXPERIMENTAL
Intervention: CET plus D-cycloserine (50 mg)
Number of subjects: 76
Study 25697860 — intervention group
Group type: COMPARATOR
Intervention: CET plus placebo
Number of subjects: 76
Study 23035053 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental practice (MP) for 20 min
Number of subjects: 40
Study 23035053 — intervention group
Group type: COMPARATOR
Intervention: Control group (didactic teaching session for 20 min)
Number of subjects: 40
Study 21604926 — intervention group
Group type: EXPERIMENTAL
Intervention: FANCI (First Steps Acute Neurobehavioural and Cognitive Intervention)
Number of subjects: 72
Study 21604926 — intervention group
Group type: COMPARATOR
Intervention: Control (watching videos)
Number of subjects: 72
Study 19655818 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardioselective beta-adrenoceptor antagonists (CSB); 212 patients (51% of 412 evaluable patients) were taking CSB.
Number of subjects: 222
Study 19655818 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-diabetic patients); not explicitly defined in the abstract.
Number of subjects: 222
Study 16754416 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg atomoxetine QD
Number of subjects: 218
Study 16754416 — intervention group
Group type: COMPARATOR
Intervention: 40 mg atomoxetine BID
Number of subjects: 218
Study 16754416 — intervention group
Group type: EXPERIMENTAL
Intervention: Both QD and BID treatments
Number of subjects: 218
Study 15317833 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg simvastatin
Number of subjects: 12
Study 15317833 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg fenofibrate
Number of subjects: 12
Study 11746067 — intervention group
Group type: EXPERIMENTAL
Intervention: COPE program
Number of subjects: 42
Study 11746067 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (audiotaped information)
Number of subjects: 42
Study 9243686 — intervention group
Group type: EXPERIMENTAL
Intervention: HMEF (Pall BB25)
Number of subjects: 40
Study 9243686 — intervention group
Group type: COMPARATOR
Intervention: Control group without HMEF
Number of subjects: 40
Study 8485533 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 0
Study 8485533 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3222359 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg caffeine
Number of subjects: 95
Study 3222359 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (200 mg and 400 mg)
Number of subjects: 95
Study 3222359 — intervention group
Group type: EXPERIMENTAL
Intervention: High-to-moderate caffeine users
Number of subjects: 95
Study 3222359 — intervention group
Group type: COMPARATOR
Intervention: 0 mg caffeine (control)
Number of subjects: 95
Study 29589138 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutated genes (PIK3CA, BRAF, KIT, PDGFRA, AKT1)
Number of subjects: 135
Study 29589138 — intervention group
Group type: COMPARATOR
Intervention: Wild-type tumors
Number of subjects: 135
Study 28516793 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine consumption
Number of subjects: 157
Study 28516793 — intervention group
Group type: COMPARATOR
Intervention: White wine consumption
Number of subjects: 157
Study 28516793 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 157
Study 26286133 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mL 4.2% sodium bicarbonate
Number of subjects: 20
Study 26286133 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL 4.2% sodium bicarbonate
Number of subjects: 20
Study 26286133 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mL 2.1% sodium bicarbonate
Number of subjects: 20
Study 26286133 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 20
Study 23447103 — intervention group
Group type: EXPERIMENTAL
Intervention: Peaceful Mind cognitive-behavioral therapy for anxiety in persons with dementia; details on dosage and duration not specified.
Number of subjects: 0
Study 23447103 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified; details on intervention not available.
Number of subjects: 0
Study 16898281 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-confidence
Number of subjects: 246
Study 16898281 — intervention group
Group type: EXPERIMENTAL
Intervention: Worry and somatic symptom intensity
Number of subjects: 246
Study 16898281 — intervention group
Group type: COMPARATOR
Intervention: High levels of self-confidence and low symptom intensity
Number of subjects: 246
Study 12525233 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (n = 87)
Number of subjects: 173
Study 12525233 — intervention group
Group type: COMPARATOR
Intervention: Stretching control group (n = 86)
Number of subjects: 173
Study 11601037 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 3 ng/kg
Number of subjects: 60
Study 11601037 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 6 ng/kg
Number of subjects: 60
Study 11601037 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane in oxygen without any other drugs (Control Group)
Number of subjects: 60
Study 7776391 — intervention group
Group type: EXPERIMENTAL
Intervention: syrup with a 10-ml measuring cup
Number of subjects: 400
Study 7776391 — intervention group
Group type: EXPERIMENTAL
Intervention: syrup with a 5-ml measuring spoon
Number of subjects: 400
Study 7776391 — intervention group
Group type: EXPERIMENTAL
Intervention: tablets
Number of subjects: 400
Study 7776391 — intervention group
Group type: EXPERIMENTAL
Intervention: single-dose sachets of antibiotic powder
Number of subjects: 400
Study 2098143 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime (1 g intravenous infusion one hour before operation)
Number of subjects: 60
Study 2098143 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (1 g intravenous infusion one hour before operation)
Number of subjects: 60
Study 2098143 — intervention group
Group type: COMPARATOR
Intervention: Control (without antibiotics)
Number of subjects: 60
Study 6253099 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy (RT) alone: 4500 rads in 5-6 weeks to primary tumor and regional lymph nodes, and 3500 rads in 2 1/2 weeks to brain as prophylaxis.
Number of subjects: 70
Study 6253099 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT) + chemotherapy (CT) with cyclophosphamide (500 mg/m2), Adriamycin (50 mg/m2), and DTIC (250 mg/m2) every 3 weeks for two cycles before RT and seven cycles post-RT.
Number of subjects: 70
Study 6253099 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + CT
Number of subjects: 70
Study 6253099 — intervention group
Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 70
Study 30429927 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg IV ketamine
Number of subjects: 34
Study 30429927 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 34
Study 26390231 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate
Number of subjects: 0
Study 26390231 — intervention group
Group type: COMPARATOR
Intervention: Rivaroxaban
Number of subjects: 0
Study 25809682 — intervention group
Group type: EXPERIMENTAL
Intervention: Green leafy vegetable (cassia)
Number of subjects: 19
Study 25809682 — intervention group
Group type: COMPARATOR
Intervention: Milk
Number of subjects: 19
Study 25809682 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D
Number of subjects: 19
Study 25809682 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum PTH
Number of subjects: 19
Study 23864538 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg purified (-)-epicatechin perfused into an isolated jejunal segment
Number of subjects: 8
Study 20299396 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunbed use
Number of subjects: 9310
Study 20299396 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunbed use in the north
Number of subjects: 9310
Study 20299396 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunbed use in the Six Cities Study
Number of subjects: 9310
Study 20299396 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean age of first use
Number of subjects: 9310
Study 20299396 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly sunbed use
Number of subjects: 9310
Study 20299396 — intervention group
Group type: EXPERIMENTAL
Intervention: Home sunbed use
Number of subjects: 9310
Study 20299396 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised sunbed use
Number of subjects: 9310
Study 19127801 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefper injection (1.5 g cefoperazone and sulbactam)
Number of subjects: 24
Study 19127801 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulperazon injection (1.5 g cefoperazone and sulbactam)
Number of subjects: 24
Study 15889524 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenmai Injection plus routine treatment
Number of subjects: 48
Study 15889524 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment only
Number of subjects: 48
Study 12652091 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-h workshop on problem drinking and alcohol dependence
Number of subjects: 76
Study 12652091 — intervention group
Group type: COMPARATOR
Intervention: 3-h workshop on depression
Number of subjects: 76
Study 10498560 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (1.0-g dose)
Number of subjects: 96
Study 10498560 — intervention group
Group type: COMPARATOR
Intervention: Penicillin G benzathine
Number of subjects: 96
Study 10498560 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 96
Study 8556221 — intervention group
Group type: EXPERIMENTAL
Intervention: Diarex Lactab (test preparation)
Number of subjects: 24
Study 8556221 — intervention group
Group type: COMPARATOR
Intervention: Imodium capsules (reference preparation)
Number of subjects: 24
Study 1682783 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine (50 mg)
Number of subjects: 12
Study 1682783 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine (60 mg)
Number of subjects: 12
Study 1682783 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 6109585 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevantolol 75 mg
Number of subjects: 6
Study 6109585 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevantolol 150 mg
Number of subjects: 6
Study 6109585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31082727 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional rituximab
Number of subjects: 21
Study 31082727 — intervention group
Group type: COMPARATOR
Intervention: Intralesional triamcinolone
Number of subjects: 21
Study 28933798 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin 10 mg
Number of subjects: 23
Study 28933798 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecarfarin 30 mg
Number of subjects: 23
Study 28933798 — intervention group
Group type: COMPARATOR
Intervention: Control group (Healthy Volunteers)
Number of subjects: 23
Study 24989721 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral antioxidants in the form of multivitamins and minerals (amino acid chelated)
Number of subjects: 218
Study 24989721 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antioxidants)
Number of subjects: 218
Study 23772021 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on social cognitive theory (7 sessions of 60 minutes)
Number of subjects: 82
Study 23772021 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 82
Study 21852196 — intervention group
Group type: EXPERIMENTAL
Intervention: Lunch is in the Bag intervention
Number of subjects: 6
Study 19302638 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Spinal Epidural (CSE)
Number of subjects: 1052
Study 19302638 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Dose Infusion (LDI)
Number of subjects: 1052
Study 19302638 — intervention group
Group type: COMPARATOR
Intervention: High-Dose Epidural (Control)
Number of subjects: 1052
Study 18162669 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nailing (IN)
Number of subjects: 58
Study 18162669 — intervention group
Group type: COMPARATOR
Intervention: Fixed angle blade plating (BP)
Number of subjects: 58
Study 15513323 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE + MPA (n = 15)
Number of subjects: 28
Study 15513323 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 28
Study 11216925 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease inhibitor-resistant isolates
Number of subjects: 14
Study 11216925 — intervention group
Group type: COMPARATOR
Intervention: Protease inhibitor-sensitive isolates
Number of subjects: 14
Study 11216925 — intervention group
Group type: COMPARATOR
Intervention: Protease inhibitor (PI)
Number of subjects: 14
Study 9850370 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 cmH2O PEEP
Number of subjects: 67
Study 9850370 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 cmH2O PEEP
Number of subjects: 67
Study 9850370 — intervention group
Group type: COMPARATOR
Intervention: Zero PEEP
Number of subjects: 67
Study 7861712 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent calcitriol therapy (oral or intraperitoneal doses) for 12 months
Number of subjects: 14
Study 7861712 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent calcitriol therapy
Number of subjects: 14
Study 2518862 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 micrograms enprostil
Number of subjects: 128
Study 2518862 — intervention group
Group type: COMPARATOR
Intervention: 150 mg ranitidine
Number of subjects: 128
Study 181692 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (1,000 mg daily)
Number of subjects: 6
Study 181692 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (40 mg daily)
Number of subjects: 6
Study 31714621 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol plus risperidone
Number of subjects: 62
Study 31714621 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus risperidone
Number of subjects: 62
Study 31297965 — intervention group
Group type: EXPERIMENTAL
Intervention: bexagliflozin (20 mg)
Number of subjects: 288
Study 31297965 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 288
Study 28550977 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe (10mg/day) and Simvastatin (40mg/day) combination therapy
Number of subjects: 57
Study 28550977 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin (40mg/day)
Number of subjects: 57
Study 24517252 — intervention group
Group type: EXPERIMENTAL
Intervention: Danoprevir/r 200/100 mg plus P/R for 24 weeks (Arm A)
Number of subjects: 473
Study 24517252 — intervention group
Group type: EXPERIMENTAL
Intervention: Danoprevir/r 100/100 mg plus P/R for 24 weeks (Arm B)
Number of subjects: 473
Study 24517252 — intervention group
Group type: EXPERIMENTAL
Intervention: Danoprevir/r 50/100 mg plus P/R for 24 weeks (Arm C)
Number of subjects: 473
Study 24517252 — intervention group
Group type: EXPERIMENTAL
Intervention: Danoprevir/r 100/100 mg plus P/R for 12 or 24 weeks (Arm D)
Number of subjects: 473
Study 24517252 — intervention group
Group type: COMPARATOR
Intervention: P/R alone for 48 weeks (Arm E)
Number of subjects: 473
Study 24517252 — intervention group
Group type: EXPERIMENTAL
Intervention: Danoprevir/r plus P/R in G1a-infected patients
Number of subjects: 473
Study 24517252 — intervention group
Group type: EXPERIMENTAL
Intervention: Danoprevir/r plus P/R in G1b-infected patients
Number of subjects: 473
Study 24517252 — intervention group
Group type: EXPERIMENTAL
Intervention: Danoprevir/r plus P/R in G4-infected patients
Number of subjects: 473
Study 22382875 — intervention group
Group type: EXPERIMENTAL
Intervention: LED group (treadmill training with phototherapy, n=10)
Number of subjects: 30
Study 22382875 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (treadmill training, n=10)
Number of subjects: 30
Study 22382875 — intervention group
Group type: COMPARATOR
Intervention: Sedentary group (n=10)
Number of subjects: 30
Study 20889211 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose peginterferon-α2a 90 μg/week
Number of subjects: 129
Study 20889211 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 129
Study 19091452 — intervention group
Group type: EXPERIMENTAL
Intervention: Parallel-sided glass-fiber posts with hybrid composite core material
Number of subjects: 192
Study 19091452 — intervention group
Group type: EXPERIMENTAL
Intervention: Parallel-sided glass-fiber posts with dual-cure composite core material
Number of subjects: 192
Study 19091452 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapered glass-fiber posts with hybrid composite core material
Number of subjects: 192
Study 19091452 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapered glass-fiber posts with dual-cure composite core material
Number of subjects: 192
Study 17182419 — intervention group
Group type: EXPERIMENTAL
Intervention: In-Person Aftercare
Number of subjects: 177
Study 17182419 — intervention group
Group type: COMPARATOR
Intervention: Telephone Aftercare
Number of subjects: 177
Study 17182419 — intervention group
Group type: COMPARATOR
Intervention: No-Active Aftercare
Number of subjects: 177
Study 12616178 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral graded activity and problem-solving therapy (GAPS)
Number of subjects: 84
Study 12616178 — intervention group
Group type: COMPARATOR
Intervention: Behavioral graded activity and group education (GAGE)
Number of subjects: 84
Study 11771959 — intervention group
Group type: EXPERIMENTAL
Intervention: hsp90 protein levels in SLE patients
Number of subjects: 0
Study 11771959 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 levels in SLE patients
Number of subjects: 0
Study 8694309 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mL/kg crystalloid volume
Number of subjects: 55
Study 8694309 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL/kg crystalloid volume
Number of subjects: 55
Study 8694309 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mL/kg crystalloid volume
Number of subjects: 55
Study 1563055 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl given before delivery
Number of subjects: 64
Study 1563055 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl given after delivery
Number of subjects: 64
Study 3926848 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with intraaortic balloon pumping and intravenous nitroglycerin for 4 to 5 days
Number of subjects: 20
Study 3926848 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with intraaortic balloon pumping and intravenous nitroglycerin
Number of subjects: 20
Study 3926848 — intervention group
Group type: COMPARATOR
Intervention: Routine management
Number of subjects: 20
Study 29120861 — intervention group
Group type: EXPERIMENTAL
Intervention: Active 20Hz rTMS at 110% of Motor Threshold
Number of subjects: 29
Study 29120861 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 29
Study 28066111 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-cost brand (LCB) amlodipine 5 mg once daily for 6 weeks
Number of subjects: 28
Study 28066111 — intervention group
Group type: COMPARATOR
Intervention: Innovator brand (IB) amlodipine 5 mg once daily for 6 weeks
Number of subjects: 28
Study 24251855 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day Family Constellation Seminars (FCSs)
Number of subjects: 208
Study 24251855 — intervention group
Group type: COMPARATOR
Intervention: Wait-list group
Number of subjects: 208
Study 23076666 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial counselling
Number of subjects: 42
Study 23076666 — intervention group
Group type: COMPARATOR
Intervention: Information brochure about dementia
Number of subjects: 42
Study 21510459 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone at a dose of 4 microg/Kg/day
Number of subjects: 26
Study 21510459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 18951261 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol Diskus 100/50 mcg BID (FSC)
Number of subjects: 647
Study 18951261 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 100 mcg BID
Number of subjects: 647
Study 18951261 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol (SAL) 50 mcg BID
Number of subjects: 647
Study 18951261 — intervention group
Group type: COMPARATOR
Intervention: Montelukast (MON) 10 mg once daily
Number of subjects: 647
Study 16160735 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone treatment
Number of subjects: 38
Study 12020486 — intervention group
Group type: EXPERIMENTAL
Intervention: VANQWISH stress test criteria (exercise and pharmacologic nuclear stress testing)
Number of subjects: 385
Study 12020486 — intervention group
Group type: EXPERIMENTAL
Intervention: FRISC‐II criteria for catheterization
Number of subjects: 385
Study 10207534 — intervention group
Group type: EXPERIMENTAL
Intervention: Tunnel restorations using glass cermet cement, Ketac Silver.
Number of subjects: 374
Study 7884423 — intervention group
Group type: EXPERIMENTAL
Intervention: Vincristine and dactinomycin (VA)
Number of subjects: 1062
Study 7884423 — intervention group
Group type: COMPARATOR
Intervention: Vincristine, dactinomycin, and cyclophosphamide (VA + C)
Number of subjects: 1062